FORME CRISTALLINE I D'IBRUTINIB

• 收藏
• 分享

专利权人:

CRYSTAL PHARMATECH INC.;SUZHOU PENGXU PHARMATECH CO., LTD.

发明人:

CHEN, MINHUA,ZHANG, YANFENG,YANG, CHAOHUI,ZHANG, XIAOYU,LU, FEI,GE, HENG,WANG, PENG,LI, PIXU

申请号：

CA2932059

公开号：

CA2932059A1

申请日:

2014.11.26

申请国别(地区):

CA

年份:

2015

代理人:

摘要：

Crystalline Form I of ibrutinib, processes for its preparation, pharmaceutical compositions comprising the new Form, and use of Form I of ibrutinib for treating or delaying diseases or disorders related to activity of Bruton's tyrosine kinase (BTK) proteins are disclosed. The novel Form was characterized by X-ray powder diffraction, differential scanning calorimetry, and other techniques. It can be readily prepared and is suitable for use in the preparation of solid dosage forms.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/